Related Experiment Video
Updated: Feb 13, 2026

Monitoring Tumor Metastases and Osteolytic Lesions with Bioluminescence and Micro CT Imaging
Published on: April 14, 2011
Quantitative baseline CT plaque characterization of unrevascularized non-culprit intermediate coronary stenosis
Mengmeng Yu1, Wenbin Li1, Zhigang Lu2
1Institute of Diagnostic and Interventional Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, #600, Yishan Rd, Shanghai, China.
Insights
Low attenuation plaque (LAP) in non-culprit coronary lesions predicts lesion progression and major adverse cardiac events (MACE). This finding highlights LAP as a key indicator for assessing cardiac risk in intermediate coronary stenosis.
Area of Science:
- Cardiovascular Imaging
- Interventional Cardiology
- Radiology
Background:
- Intermediate coronary stenosis requires accurate risk stratification to prevent adverse cardiac events.
- Coronary CT angiography (CCTA) provides detailed plaque characterization, aiding in risk assessment.
Purpose of the Study:
- To quantitatively assess baseline CCTA plaque characteristics of unrevascularized non-culprit intermediate coronary stenosis.
- To determine the association between these plaque features, lesion volume progression, and long-term cardiac prognosis.
Main Methods:
- Prospective enrollment of patients with intermediate coronary stenosis undergoing CCTA and invasive coronary angiography (ICA).
- Follow-up CCTA at 1-1.5 years to assess lesion volume progression.
- Analysis of high-risk plaque features and quantitative measurements, including low attenuation plaque (LAP).
Main Results:
- Low attenuation plaque (LAP) was more prevalent in lesions that progressed in volume and in patients who experienced major adverse cardiac events (MACE).
- LAP was identified as an independent predictor for both lesion volume progression (OR=16.74) and MACE (OR=4.25).
- No significant differences were observed in other quantitative plaque parameters between subgroups.
Conclusions:
- The presence of LAP in unrevascularized intermediate coronary stenosis is linked to lesion progression.
- LAP serves as an independent predictor for the occurrence of MACE, indicating its prognostic value.
Aims:
To investigate the quantitative baseline CT plaque characterization of unrevascularized non-culprit intermediate coronary stenosis and its association with lesion volume progression and long-term prognosis.
Methods:
Patients with baseline coronary CT angiography (CCTA) and invasive coronary angiography (ICA) and at least one unrevascularized non-culprit intermediate coronary stenosis were prospectively enrolled for this study. All patients were followed up by a second CCTA at 1-year to 1.5-year interval. High-risk plaque features as well as other quantitative plaque measurements were recorded.
Results:
140 patients with 165 unrevascularized non-culprit intermediate lesions were selected. Lesion volume progression was identified in 18 lesions (10.9%, 18/165) at follow-up CCTA and 15 patients experienced major adverse cardiac events (MACE) during a mean follow-up period of 51.5 months. Low attenuation plaque (LAP) was more frequently present in the lesion-progression subgroup and MACE subgroup (lesion-progression VS. non-lesion progression: 55.6% VS. 8.8% and MACE VS. MACE free: 40% VS. 12.8%, both p < 0.05), while other parameters showed no significant differences. Based on stepwise multivariable logistic regression analysis, LAP was an independent predictor (OR = 16.74, 95%CI = 5.02 to 55.84, p < 0.001) for lesion volume progression and MACE (OR = 4.25, 95%CI = 1.03 to 17.53, p = 0.046).
Conclusions:
The presence of LAP of unrevascularized non-culprit intermediate stenosis is associated with lesion volume progression and an independent predictor for MACE occurrence.
More Related Videos
05:12A Micro-CT-based Method for Characterizing Lesions and Locating Electrodes in Small Animal Brains
Published on: November 8, 2018
10:02Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
Published on: May 2, 2012
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Radiological Investigation I: X-ray and CT
The Intermediate Value Theorem
Serial Position Effect